Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas [Phase 1, Phase 2]
This clinical trial update reports the completion and posted results of a Phase 1/2 study evaluating TRC102 in combination with Temozolomide…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma [Phase 1]
A Phase 1 study of CPI-0610 in patients with progressive lymphoma has completed. The update notes the trial status as completed.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) [Phase 2]
Phase 2 pediatric trial of Genistein for various cancers was terminated, with results posted.
-
CLINICAL_TRIALS withdrawal · 2024-05-06Clinical Trial Update: Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M) [Phase 2]
A Phase 2 MATCH subprotocol trial testing nivolumab with relatlimab (BMS-986016) for LAG-3 positive tumors with mismatch repair deficiency h…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of SYNB1891 alone or with atezolizumab in adults with metastatic solid tumors or lymp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant [NA]
A completed clinical trial evaluating chaplain-delivered compassion meditation to improve quality of life in patients undergoing stem cell t…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Radiation Post-CAR T in Refractory Lymphoma [NA]
A clinical trial evaluating radiation after CAR T therapy in refractory lymphoma was terminated. Results were posted on 2024-04-10.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Pilot RCT of the PRISM Intervention for AYAs With Cancer [Phase 2]
pilot randomized Phase 2 trial evaluating the PRISM intervention for adolescents and young adults with cancer, completed.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]
Phase 1/2 clinical trial update on NK donor lymphocyte infusion following HLA-haploidentical HSCT; study status completed.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma [Phase 1, Phase 2]
Clinical trial of mocetinostat in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 [Phase 1]
Phase 1 trial of intratumorally administered STING agonist E7766 in advanced solid tumors or lymphomas has been terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) [Phase 1]
Phase 1 study of Ulevostinag (MK-1454) alone or in combination with pembrolizumab (MK-3475) in participants with advanced/metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]
A study investigating CYC140 in subjects with advanced solid tumors and lymphoma (Phase 1/Phase 2) is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]
Clinical trial update for Fadraciclib (CYC065) in advanced solid tumors and lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) [Phase 3]
Phase 3 trial comparing TAC/MTX versus TAC/MMF/PTCY for graft-versus-host disease prevention and microbiome/immune reconstitution in patient…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas [Phase 1]
A pediatric Phase 1 trial evaluating selinexor in children with recurrent or refractory solid tumors and high-grade gliomas has completed. R…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy [Phase 2]
Phase 2 trial of Xisomab 3G3 for preventing catheter-associated thrombosis in cancer patients undergoing chemotherapy was terminated; result…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update for a monoclonal antibody therapy in relapsed lymphoma after chemotherapy and autologous stem cell transplantation (Ph…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma [Phase 4]
A Phase 4 clinical trial comparing surgery alone versus surgery with additional systemic therapy regimens for stage IA/IIA nodular lymphocyt…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas [Phase 1, Phase 2]
Phase Ⅰ/Ⅱ study evaluating SHR2554 in combination with SHR1701 in advanced solid tumors and B-cell lymphomas is underway, with no current st…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas [Phase 2]
Phase 2 trial of pembrolizumab in relapsed/refractory gray-zone lymphoma, primary CNS lymphoma, and other extranodal diffuse large B-cell ly…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Pembrolizumab in Neoplasms or Lymphomas [Phase 2]
Phase 2 trial of pembrolizumab for lymphomas and dendritic cell sarcomas is suspended, with results posted in November 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Lapelga vs Gastrofil [Phase 3]
Phase 3 trial update for Lapelga versus Gastrofil in patients with Multiple Myeloma and Lymphoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Use of GnRHa During Chemotherapy for Fertility Protection [Phase 3]
Phase 3 trial investigating GnRHa during chemotherapy to protect fertility in cancer patients; currently recruiting.